Contemporary Management of HIV 2020: ART Strategies for Complex HIV Cases

Join 2 leading experts for an interactive workshop focused on HIV management scenarios requiring specialized knowledge and skills to achieve optimal outcomes, including extensive treatment experience, challenging comorbidities, and switching ART when information on treatment history/drug resistance is incomplete.

September 29, 2020 at 12:00 PM ET – For clinicians in NY/ NE

September 29, 2020 at 6:00 PM ET – For clinicians in the Southern US

September 30, 2020 at 11:30 AM ET – For clinicians in New Jersey and Delaware

September 30, 2020 at 4:00 PM ET – For clinicians in the Carolinas

October 1, 2020 at 12:00 PM CT – For clinicians in the Midwest

October 1, 2020 at 3:00 PM ET – For clinicians in DC, Maryland, and the Virginias

October 6, 2020 at 12:00 PM PT – For clinicians in the Western US

October 6, 2020 at 4:00 PM CT – For clinicians in the Southwest Region

October 7, 2020 at 12:00 PM ET – For clinicians in Pennsylvania, Ohio, Indiana and Kentucky

October 7, 2020 at 6:00 PM ET – For clinicians in Florida

Agenda

  • Introduction and program overview
  • Case-based discussion
    • Managing virologic failure in a heavily treatment-experienced patient
    • Switching ART in a patient with complex or unknown treatment history
    • First-line ART in a patient with obesity
  • Question and answer session

Faculty

Program Director
Joseph J. Eron, MD

Professor of Medicine and Epidemiology
University of North Carolina School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina

Program Director
Princy N. Kumar, MD

Professor of Medicine and Epidemiology
University of North Carolina School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina

Faculty
Roger Bedimo, MD

Professor of Medicine
Division of Infectious Diseases
University of Texas Southwestern Medical Center
Section Chief
Division of Infectious Diseases
Department of Internal Medicine
VA North Texas Health Care System
Dallas, Texas

Faculty
Eric S. Daar, MD

Chief, Division of HIV Medicine
Harbor-UCLA Medical Center
Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

Faculty
Monica Gandhi, MD, MPH

Professor of Medicine
Division of HIV, Infectious Diseases, and Global Medicine
University of California, San Francisco
Medical Director
Ward 86 HIV Clinic
San Francisco General Hospital
San Francisco, California

Faculty
Geeta Gupta, MD

Professor
Director,
AIDS Education and Training Center
University of California, Irvine
Orange, California

Faculty
W. David Hardy, MD

Scientific and Medical Consultant
Adjunct Professor of Medicine

Division of Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, Maryland

Faculty
Lisa Hightow-Weidman, MD, MPH

Professor of Medicine and Health Behavior
University of North Carolina School of Medicine
Director, Behavior and Technology Lab (BATLab) and UNC
University of North Carolina
Chapel Hill, North Carolina

Faculty
Daniel R. Kuritzkes, MD

Chief, Division of Infectious Diseases
Brigham and Women's Hospital
Harriet Ryan Albee Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Faculty
Mary W. Montgomery, MD

Instructor of Medicine
Harvard Medical School
Associate Professor
Division of Infectious Disease
Department of Medicine
Brigham and Women's Hospital
Boston, Massachusetts

Faculty
William R. Short, Other

Faculty
Daniel A. Solomon, MD

Instructor of Medicine
Division of Infectious Diseases
Harvard Medical School
Associate Physician
Division of Infectious Diseases
Brigham and Women's Hospital
Boston, Massachusetts

Faculty
Heidi Swygard, MD

Clinical Associate Professor of Medicine
Division of Infectious Diseases
Department of Medicine
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Faculty
Babafemi Taiwo, MBBS

Gene Stollerman Professor of Medicine
Chief, 
Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Faculty
Marc A. Tribble, MD

Clinical Assistant Professor
Division of Infectious Diseases
Baylor University Medical Center at Dallas
Dallas, Texas

Faculty
Timothy J. Wilkin, MD, MPH

Associate Professor of Medicine
Co-Director, Cornell Clinical Trials Unit
Weill Cornell Medical College
New York, New York

Faculty
David A. Wohl, MD

Professor of Medicine
School of Medicine
Site Leader,  AIDS Clinical Trials Unit-Chapel Hill
University of North Carolina at Chapel Hill
Director, North Carolina AIDS Training and Education Center
Chapel Hill, North Carolina
Co-Director, HIV Services
North Carolina Department of Correction
Raleigh, North Carolina

Goal Statement
The goal of this activity is to improve learners’ competence in providing optimal care for HIV-infected patients through the appropriate use of contemporary ARV regimens.

Target Audience
This program is intended for physicians, registered nurses, physician assistants, pharmacists, and other healthcare professionals who provide care for patients with HIV infection.

Learning Objectives

  • Apply optimized management strategies for patients with virologic failure in the setting of an extensive treatment history and multiclass drug resistance
  • Formulate individualized ART switch regimens for patients who require a change in HIV treatment but have incomplete information on treatment/drug resistance history
  • Provide effective care for patients experiencing challenging comorbidities that may complicate ART management

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours.

Continuing Pharmacy Education
CCO designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education. UAN: JA4008176-0000-20-100-L02-P

Type of Activity: Application

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.